BioPlus Co Ltd
KOSDAQ:099430
BioPlus Co Ltd
Stock-Based Compensation
BioPlus Co Ltd
Stock-Based Compensation Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Stock-Based Compensation | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Stock-Based Compensation
₩66.4m
|
CAGR 3-Years
23%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Suheung Co Ltd
KRX:008490
|
Stock-Based Compensation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
SD Biosensor Inc
KRX:137310
|
Stock-Based Compensation
₩905.4m
|
CAGR 3-Years
-64%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Stock-Based Compensation
₩11.4B
|
CAGR 3-Years
15%
|
CAGR 5-Years
37%
|
CAGR 10-Years
28%
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Stock-Based Compensation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
I
|
Interojo Co Ltd
KOSDAQ:119610
|
Stock-Based Compensation
-₩18.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
BioPlus Co Ltd
Glance View
BioPlus Co., Ltd. is engaged in the manufacturing and supplying of diverse dermal fillers. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2021-09-27. The firm is engaged in the production and sale of biomaterials for tissue restoration used for temporary improvement of facial wrinkles, namely hyaluronic acid fillers. In addition, the Company is engaged in the production and sale of anti-adhesion agents that reduce the formation of adhesions in surgical areas, biomaterials for joint tissue repair, and other products.
See Also
What is BioPlus Co Ltd's Stock-Based Compensation?
Stock-Based Compensation
66.4m
KRW
Based on the financial report for Dec 31, 2024, BioPlus Co Ltd's Stock-Based Compensation amounts to 66.4m KRW.
What is BioPlus Co Ltd's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 5Y
-10%
Over the last year, the Stock-Based Compensation growth was -65%. The average annual Stock-Based Compensation growth rates for BioPlus Co Ltd have been 23% over the past three years , -10% over the past five years .
